Side Effects of dipyridamole: A Synthesis of Findings from 28 Studies

  1. Home
  2. Side Effects of dipyridamole
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of dipyridamole: A Synthesis of Findings from 28 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of dipyridamole: A Synthesis of Findings from 28 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Findings

Dipyridamole is a medication that inhibits platelet aggregation and is used to prevent angina and stroke. Dipyridamole works by acting on adenosine receptors to dilate blood vessels and improve blood flow. 28 3 8 2 20 Dipyridamole increases myocardial blood flow and is used as a drug to assess myocardial blood flow. 17 5 9 4 Dipyridamole inhibits platelet aggregation and is used to prevent stroke and myocardial infarction. 3 1 19 Dipyridamole has been shown to lower blood pressure in patients with diabetes. 11 Dipyridamole works by acting on adenosine receptors to dilate blood vessels and is used to treat peripheral arterial disease. 11

Reasons for Side Effects

The side effects of dipyridamole are thought to be caused by its action on adenosine receptors. Adenosine receptors are found in various tissues, including the heart, blood vessels, lungs, and brain. Dipyridamole can act on these adenosine receptors in these tissues, leading to side effects such as vasodilation, decreased heart rate, and bronchoconstriction. 7 27

Common Side Effects

Headache

Dipyridamole can cause headaches. 15 1 16 Headaches caused by dipyridamole are thought to be caused by its action on adenosine receptors. Dipyridamole can act on adenosine receptors to dilate blood vessels, which can lead to headaches. 15

Dizziness

Dipyridamole can cause dizziness. 17 Dizziness caused by dipyridamole may be caused by a drop in blood pressure. 17

Nausea

Dipyridamole can cause nausea and vomiting. 17 Nausea and vomiting caused by dipyridamole may be caused by stomach discomfort. 17

Rash

Dipyridamole can cause a rash. 17 Rashes caused by dipyridamole may be caused by an allergic reaction. 17

Difficulty Breathing

Dipyridamole can cause difficulty breathing. 17 Difficulty breathing caused by dipyridamole may be caused by bronchoconstriction. 17

Chest Pain

Dipyridamole can cause chest pain. 17 Chest pain caused by dipyridamole may be caused by myocardial ischemia. 17

Decreased Heart Rate

Dipyridamole can cause a decreased heart rate. 17 A decreased heart rate caused by dipyridamole is thought to be caused by its action on adenosine receptors. 17

Decreased Blood Pressure

Dipyridamole can cause a decreased blood pressure. 17 A decreased blood pressure caused by dipyridamole may be caused by vasodilation. 17

Gastrointestinal Side Effects

Dipyridamole can cause gastrointestinal side effects. 17 Gastrointestinal side effects caused by dipyridamole include nausea, vomiting, and diarrhea. 17

Side Effects Management

Headache Management

Headaches caused by dipyridamole usually appear soon after starting the medication and decrease within a few days. 15 If headaches are severe, consult your doctor. 15 Your doctor may prescribe other medications to relieve headache symptoms. 15

Dizziness Management

Dizziness caused by dipyridamole usually appears soon after starting the medication and decreases within a few days. 17 If dizziness is severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve dizziness symptoms. 17

Nausea Management

Nausea caused by dipyridamole usually appears soon after starting the medication and decreases within a few days. 17 If nausea is severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve nausea symptoms. 17

Rash Management

Rashes caused by dipyridamole usually appear soon after starting the medication and decrease within a few days. 17 If rashes are severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve rash symptoms. 17

Difficulty Breathing Management

Difficulty breathing caused by dipyridamole usually appears soon after starting the medication and decreases within a few days. 17 If difficulty breathing is severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve difficulty breathing symptoms. 17

Chest Pain Management

Chest pain caused by dipyridamole usually appears soon after starting the medication and decreases within a few days. 17 If chest pain is severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve chest pain symptoms. 17

Decreased Heart Rate Management

A decreased heart rate caused by dipyridamole usually appears soon after starting the medication and decreases within a few days. 17 If a decreased heart rate is severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve decreased heart rate symptoms. 17

Decreased Blood Pressure Management

A decreased blood pressure caused by dipyridamole usually appears soon after starting the medication and decreases within a few days. 17 If a decreased blood pressure is severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve decreased blood pressure symptoms. 17

Gastrointestinal Side Effects Management

Gastrointestinal side effects caused by dipyridamole usually appear soon after starting the medication and decrease within a few days. 17 If gastrointestinal side effects are severe, consult your doctor. 17 Your doctor may prescribe other medications to relieve gastrointestinal side effects. 17

Comparison Between Studies

Commonalities

Many studies have shown that dipyridamole can cause side effects such as headaches, dizziness, nausea, rash, difficulty breathing, chest pain, decreased heart rate, and decreased blood pressure. 28 24 3 5 17 16 4 25 10

Differences

The incidence and severity of side effects caused by dipyridamole may vary depending on the study. 28 24 3 5 17 16 4 25 10 This is because the factors such as the age, sex, health status, and amount of dipyridamole taken by the study subjects vary. 28 24 3 5 17 16 4 25 10

Real-Life Application Notes

Dipyridamole is an effective drug for preventing heart disease and stroke, but it comes with a risk of side effects. Before taking dipyridamole, consult your doctor to make sure it is the right drug for your health condition. 28 24 3 5 17 16 4 25 10

Limitations of Current Research

Research on the side effects of dipyridamole is still not complete. 28 24 3 5 17 16 4 25 10 In particular, it is not yet fully understood what side effects may occur when dipyridamole is taken for long periods. 28 24 3 5 17 16 4 25 10

Future Research Directions

Research on the side effects of dipyridamole needs to continue. 28 24 3 5 17 16 4 25 10 In particular, research is needed to elucidate the mechanisms by which dipyridamole causes side effects when taken for long periods. 28 24 3 5 17 16 4 25 10

Conclusion

Dipyridamole is an effective medication for preventing heart disease and stroke, but it comes with a risk of side effects. Before taking dipyridamole, consult your doctor to make sure it is the right medication for your health condition. Research on the side effects of dipyridamole is still not complete. In the future, we need to continue research on dipyridamole side effects and clarify its mechanisms. 28 24 3 5 17 16 4 25 10

Literature analysis of 28 papers
Positive Content
28
Neutral Content
0
Negative Content
0
Article Type
3
0
1
11
27
1.

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.

Author: GuthrieRobert

Reduced stroke risk
Bleeding risk
Headache risk

This article discusses the risk of secondary events following noncardioembolic ischemic stroke or transient ischemic attack (TIA), and the use of antiplatelet therapy to reduce this risk. The article also discusses the potential side effects of antiplatelet therapy, particularly bleeding, and strategies to reduce the risk of side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

2.

[Secondary prevention with clopidogrel after TIA or stroke].

Author: ZuurbierS M Yvonne, VermeerSarah E, HilkensPieter H E, AlgraAle, RoosYvo B W E M

Antiplatelet therapy for TIA/stroke
Side effects of antiplatelet therapy

This article discusses the current guidelines and treatment strategies for secondary prevention after TIA or stroke. Clopidogrel monotherapy is considered a viable alternative to the combination of acetylsalicylic acid and dipyridamole.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : Dutch

3.

Update on antiplatelet agents, including MATCH, CHARISMA, and ESPRIT.

Author: SkliutMaryna, JamiesonDara G

Reduced stroke risk
Stroke prevention
Hemorrhage

Aspirin plus extended-release dipyridamole is effective in preventing recurrent ischemic stroke, while clopidogrel plus aspirin is not.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

4.

Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging.

Author: LinLi-Fan, ChengCheng-Yi, HouCheng-Han, KuChih-Hung, TsengNeng-Chuan, ShenDaniel H Y

Relief of mild AEs

Low-dose (≤50mg) aminophylline is sufficient to relieve mild dipyridamole-related AEs during stress MPI.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

5.

Advances in pharmacologic stress agents: focus on regadenoson.

Author: JohnsonSara G, PetersScott

Improved stress imaging
Reduced side effects

This review discusses the need for improved pharmacologic stress agents for myocardial perfusion imaging, highlighting the advantages of A(2A)-selective agonists, such as regadenoson.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

6.

Safety and diagnostic accuracy of intravenous accelerated high-dose dipyridamole-atropine stress echocardiography.

Author: MinardiGiovanni, ManzaraCarla C, PulignanoGiovanni, CarmeniniEnrico, GaudioCarlo, GiovanniniEzio

Cost-effective
Good diagnostic accuracy
Shorter imaging time
Minor side effects

Accelerated high-dose dipyridamole echocardiography is a safe and effective method for diagnosing coronary artery disease, with high sensitivity, specificity, and diagnostic accuracy.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

7.

Purine nucleosides stimulate Na/K ATPase, and prolong survival in hemorrhagic shock.

Author: DarlingtonDaniel N, GannDonald S

Na/K ATPase stimulation
Plasma potassium reduction
Survival prolongation
Bradycardia

This study searched for adenosine analogs that stimulate Na/K ATPase activity without the side effect of bradycardia. Adenosine is known to stimulate Na/K ATPase activity and lower plasma potassium, but it also causes bradycardia. The study aimed to identify analogs that could provide the beneficial effects of adenosine without the adverse effect of bradycardia.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Language : English

8.

Dipyridamole/aspirin combination in secondary stroke prevention: effects on absolute myocardial blood flow and coronary vascular resistance.

Author: SchaeferW M, KochK C, NowakB, NothJ, BuellU, WeissP H

Stroke prevention
Cardiac side effects

A combination of dipyridamole and aspirin is more effective in preventing stroke after a stroke or transient ischemic attack compared to placebo, aspirin or dipyridamole alone. However, intravenous dipyridamole can increase myocardial blood flow and potentially lead to ischemic wall motion abnormalities in patients with coronary artery disease.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

9.

Regadenoson in the detection of coronary artery disease.

Author: BuhrChristiane, GösslMario, ErbelRaimund, EggebrechtHolger

Myocardial perfusion imaging
Atrioventricular conduction disturbances
Bronchospasm

This article reviews the preclinical and clinical data on regadenoson, a highly subtype-selective, potent, low-affinity A2A adenosine receptor agonist, as a potential coronary vasodilator for myocardial perfusion imaging studies. Regadenoson achieves maximum coronary hyperemia equivalent to adenosine but with a longer duration of action, resulting in fewer side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

10.

Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation.

Author: LeeSin-Di, HuangWei-Chun, PengNan-Jing, HuChin

Effective treatment
Adverse effects

This study aims to confirm the dynamic data on side effects associated with dipyridamole, a drug commonly used in stress myocardial perfusion scans (MPS) for managing coronary artery disease.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

11.

Dipyridamole inhibits α-amylase/α-glucosidase at sub-micromolar concentrations; in-vitro, in-vivo and theoretical studies.

Author: EsmaeiliSajjad, AzizianSarwar, ShahmoradiBahareh, MoradiSajad, ShahlaeiMohsen, KhodarahmiReza

Reduced blood glucose

Dipyridamole (DP), a drug used to dilate blood vessels, was found to inhibit the activity of α-amylase and α-glucosidase, enzymes involved in glucose absorption. In vivo studies showed a decrease in blood glucose levels after DP administration, suggesting a potential link between DP's clinical effects and its enzyme inhibition properties.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

12.

A fluorescent polarization-based assay for the identification of disruptors of the RCAN1-calcineurin A protein complex.

Author: Carme MuleroM, OrzáezMar, MesseguerJoaquim, MesseguerAngel, Pérez-PayáEnrique, Pérez-RibaMercè

Immunosuppressive effects
Calcineurin inhibition side effects

A new high-throughput fluorescence polarization assay is being developed to identify molecules that can disrupt the calcineurin-NFAT interaction. This assay has been used to identify dipyridamole and three other small molecules that have potential immunosuppressive effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

13.

Combination of cyclic nucleotide modulators with P2Y<sub>12</sub> receptor antagonists as anti-platelet therapy.

Author: ArmstrongPaul C, FerreiraPlinio M, ChanMelissa V, Lundberg SlingsbyMartina H, CrescenteMarilena, ShihChih-Chin, KirkbyNicholas S, HobbsAdrian J, WarnerTimothy D

Platelet quiescence
Side effects

Prostacyclin and nitric oxide help maintain platelet quiescence by increasing cyclic nucleotide levels. This study explored the synergistic relationship between cyclic nucleotides and P2Y12 receptor inhibition in platelets. Drugs that modulate cyclic nucleotide tone, like NO-sensitive guanylyl cyclase activators and PDE inhibitors, can be used to inhibit platelets, but the doses needed often cause side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

15.

Dipyridamole and headache--a pilot study of initial dose titration.

Author: LindgrenArne, HustedSteen, StaafGert, ZieglerBirgitte

Reduced headache incidence
Side effects

The study investigated whether titrating dipyridamole may reduce headache, a common side effect of dipyridamole in patients after stroke or TIA. The results suggest that titration with an initially lower dose of dipyridamole may reduce headache and increase compliance.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

16.

Advances in pharmacologic agents in imaging: new A2A receptor agonists.

Author: CerqueiraManuel D

Easier administration
Lower side effects
Subjective side effects

Regadenoson and binodenoson, selective adenosine A2A receptor agonists, are being investigated as potential pharmacologic stress agents for myocardial perfusion imaging. These agents offer a safer alternative to dipyridamole and adenosine, with fewer side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

17.

Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.

Author: HendelRobert C, BatemanTimothy M, CerqueiraManuel D, IskandrianAmi E, LeppoJeffrey A, BlackburnBrent, MahmarianJohn J

Detect myocardial hypoperfusion
Chest discomfort
Dyspnea
Flushing

Regadenoson, a selective A2A adenosine receptor agonist, was well-tolerated and as effective as adenosine for detecting and quantifying the extent of hypoperfusion observed with SPECT perfusion imaging. Side effects were generally mild in severity and self-limiting. The 400 microg dose was better tolerated than the 500 microg dose. Phase III clinical trials are now underway.

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

18.

The safety and tolerability of adenosine in patients with obstructive airways disease.

Author: van GaalWilliam J, CouthinoB, ChanM, AllmanK C

Myocardial perfusion scintigraphy

This study investigated the safety of adenosine in 46 patients with a history of COPD or asthma undergoing adenosine stress myocardial perfusion scintigraphy. Adenosine was safe and well tolerated in this cohort of patients.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
LetterA written message for communication and exchange of information between individuals.

Language : English

19.

Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.

Author: CrownNatalie, MysakTania

Aspirin-ER dipyridamole effective
Angina risk

The study found that fixed-dose combination aspirin-extended-release (ER) dipyridamole was not associated with an increased risk of cardiovascular events in patients with ischemic heart disease. However, individual patient factors merit consideration when choosing an antiplatelet agent for stroke prevention.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

21.

Dipyridamole-dobutamine stress echocardiography for the detection of myocardial ischemia in patients with hypertension.

Author: MilosavljevicJelica, OstojicMiodrag, MarinkovicJelena

Myocardial ischemia detection

Both dipyridamole-dobutamine stress echocardiography (Dip-Dob) and dipyridamole-atropine stress echocardiography (Dip-Atro) tests were found to have high diagnostic accuracy in detecting myocardial ischemia in hypertensive patients. Dip-Dob showed a more pronounced ability to provoke myocardial ischemia than Dip-Atro.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

22.

Novel glucocorticoids: where are we now and where do we want to go?

Author: ButtgereitFrank, SpiesCornelia M, BijlsmaJ W J

Inflammation treatment
Side effects

Glucocorticoids (GCs) are effective treatments for many inflammatory conditions, but they can also cause side effects. This study explores new approaches to improve the benefit-to-risk ratio of GC therapy, including chronotherapeutic formulations, selective GC receptor agonists, and liposomal GCs.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

23.

Development of a sustained-release system for perivascular delivery of dipyridamole.

Author: ZhuWeiwei, MasakiTakahisa, BaeYou Han, RathiRamesh, CheungAlfred K, KernSteven E

Neointimal hyperplasia prevention

A combination of PLGA microspheres and ReGel was developed for sustained perivascular delivery of dipyridamole, an antiproliferative drug, to prevent graft failure in dialysis patients.

Evaluation StudyResearch that systematically evaluates the effectiveness of a particular program or policy. It measures its outcomes and provides important information for future decision-making.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Language : English

24.

Complications during pharmacological stress echocardiography: a video-case series.

Author: VargaAlbert, KraftGiuliano, LakatosFerenc, BigiRiccardo, PayaRafael, PicanoEugenio

Coronary artery disease diagnosis
Side effects

This article discusses the safety of stress echocardiography, a noninvasive diagnostic tool for coronary artery disease. The article emphasizes the importance of choosing the appropriate stress test based on patient safety considerations. While both dobutamine and dipyridamole stress echo testing are generally safe, complications or side effects can still occur.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

25.

Epidural therapy for the treatment of severe pre-eclampsia in non labouring women.

Author: RayAmita, RaySujoy

Increased uteroplacental blood flow

Pre-eclampsia is a serious pregnancy disorder characterized by high blood pressure and multi-organ involvement, leading to significant maternal and fetal morbidity and mortality. This review evaluates the evidence for the benefits and risks of epidural therapy in managing severe pre-eclampsia, aiming to define the current evidence level and identify areas for further research.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

26.

Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Author: AhlbergAlan W, BaghdasarianSarkis B, AtharHaris, ThompsenJeffrey P, KattenDeborah M, NobleGavin L, MamkinIgor, ShahAnuj R, LekaIvette A, HellerGary V

Effective risk stratification

Combining symptom-limited exercise and dipyridamole stress with gated SPECT imaging was effective for risk stratification in patients with coronary artery disease.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

28.

Additive effects of dipyridamole and Trolox in protecting human red cells during photodynamic treatment.

Author: BesselinkG A J, van EngelenburgF A C, EbbingI G, HilariusP M, de KorteD, VerhoevenA J

RBC protection
Virus inactivation
Photohaemolysis
RBC deterioration

This study explored the potential of dipyridamole and Trolox to protect red blood cells (RBCs) from the harmful side-effects of photodynamic treatment.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.